SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001358403-17-000167
Filing Date
2017-11-16
Accepted
2017-11-16 16:05:47
Documents
3
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A a2017q310qa.htm 10-Q/A 42059
2 EXHIBIT 31.1 exh3112017q3.htm EX-31.1 13211
3 EXHIBIT 31.2 exh3122017q3.htm EX-31.2 13503
  Complete submission text file 0001358403-17-000167.txt   69894
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36783 | Film No.: 171208080
SIC: 2834 Pharmaceutical Preparations